GNTA
Genenta Science S.p.A.Company with tickers: GNTA
CIK
1838716
CUSIP
36870W100
Shares Outstanding
23,591,020
13F Activity (30d)
8 filings
6 filers
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
| Line Item | Value | Unit | Period End | Form | Filed |
|---|---|---|---|---|---|
| Revenue | — | ||||
| Revenue (ASC 606) | — | ||||
| Cost of Revenue | — | ||||
| Gross Profit | — | ||||
| Operating Expenses | 6,603,740 | EUR | 2025-12-31 | 20-F | 2026-04-01 |
| Research & Development | 2,699,342 | EUR | 2025-12-31 | 20-F | 2026-04-01 |
| Operating Income | -6,603,740 | EUR | 2025-12-31 | 20-F | 2026-04-01 |
| Net Income | -6,529,827 | EUR | 2025-12-31 | 20-F | 2026-04-01 |
| EPS (Basic) | — | ||||
| EPS (Diluted) | -0.33 | EUR/shares | 2025-12-31 | 20-F | 2026-04-01 |